Medpace Holdings, Inc. financials

  1. Home
  2. Financials
  3. MEDP
MEDP CIK 0001668397

Source: EDGAR filings · Built 2026-06-02T03:32:11Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Free Cash Flow 681.87M 572.27M 396.73M 351.17M 235.06M 227.34M
EBITDA 563.06M 476.12M 363.15M 301.04M 219.73M 186.57M
Working Capital -354.12M -75.32M -331.30M -469.51M 133.69M 33.54M
Net Debt -360.20M -519.91M -80.96M 179.87M -314.06M -146.73M
Operating Margin 21.14% 21.19% 17.86% 19.09% 17.39% 18.04%
Net Margin 17.83% 19.17% 15.00% 16.81% 15.92% 15.70%
Return on Equity (ROE) 98.27% 48.98% 50.60% 63.50% 19.08% 18.04%
Return on Assets (ROA) 22.84% 19.25% 17.07% 18.14% 10.96% 10.45%
Current Ratio 0.74× 0.93× 0.64× 0.42× 1.24× 1.08×
Debt-to-Equity 0.30× 0.18× 0.29× 0.54× 0.15× 0.16×
Effective Tax Rate 16.82% 15.03% 15.75% 13.25% 9.91% 13.74%
Cash Conversion Ratio 1.58× 1.51× 1.53× 1.58× 1.45× 1.78×
Accruals Ratio -0.13× -0.10× -0.09× -0.11× -0.05× -0.08×
SBC % of Revenue 1.37% 1.21% 1.09% 1.47% 1.27% 1.49%
CapEx Coverage 22.75× 16.66× 11.83× 10.52× 9.31× 8.25×
Free Cash Flow Per Share $23.09 $17.88 $12.46 $10.43 $6.24 $6.03

Valuation Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
P/E Trailing (Diluted) 36.76× 26.30× 34.52× 29.18× 45.25× 36.25×
P/FCF 24.32× 18.59× 24.60× 20.37× 34.90× 23.09×
FCF Yield 4.11% 5.38% 4.06% 4.91% 2.87% 4.33%
EV / EBITDA 27.66× 20.28× 25.73× 22.54× 34.23× 25.71×
P/S 6.30× 4.83× 5.00× 4.52× 6.86× 5.34×
P/B 34.71× 12.33× 16.86× 17.09× 8.22× 6.14×

Income Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Revenue from Contract with Customer, Excluding Assessed Tax 2.53B 2.11B 1.89B 1.46B 1.14B 925.92M
Selling, General and Administrative Expense 197.56M 180.18M 161.35M 131.40M 108.42M 92.16M
Operating Income (Loss) 534.93M 446.87M 336.82M 278.70M 198.62M 167.04M
Income Tax Expense (Benefit) 91.25M 71.54M 52.87M 37.49M 20.00M 23.15M
Net Income (Loss) Attributable to Parent 451.12M 404.39M 282.81M 245.37M 181.85M 145.38M
Earnings Per Share, Basic $15.64 $13.06 $9.20 $7.57 $5.06 $4.07
Weighted Average Number of Shares Outstanding, Basic 28.85M 30.96M 30.72M 32.39M 35.86M 35.63M
Earnings Per Share, Diluted $15.28 $12.63 $8.88 $7.28 $4.81 $3.84
Weighted Average Number of Shares Outstanding, Diluted 29.53M 32.01M 31.84M 33.67M 37.70M 37.71M

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Cash and Cash Equivalents, at Carrying Value 497.05M 669.44M 245.45M 28.27M 461.30M 277.77M
Assets, Current 989.62M 1.03B 593.83M 333.96M 690.91M 473.65M
Assets 1.98B 2.10B 1.66B 1.35B 1.66B 1.39B
Liabilities, Current 1.34B 1.10B 925.13M 803.47M 557.22M 440.11M
Liabilities 1.52B 1.28B 1.10B 966.11M 707.01M 584.90M
Stockholders' Equity Attributable to Parent 459.07M 825.54M 558.95M 386.39M 952.93M 805.78M
Common Stock, Shares, Outstanding 28.37M 30.63M 30.75M 31.09M 36.01M 35.52M

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Net Cash Provided by (Used in) Operating Activities 713.22M 608.82M 433.37M 388.05M 263.33M 258.68M
Payments to Acquire Property, Plant, and Equipment 31.36M 36.55M 36.65M 36.88M 28.27M 31.34M
Net Cash Provided by (Used in) Investing Activities -31.14M -28.31M -34.63M -38.74M -31.36M -31.21M
Payments for Repurchase of Common Stock 917.39M 169.87M 144.02M 847.85M 62.10M 98.27M
Net Cash Provided by (Used in) Financing Activities -860.39M -154.01M -182.64M -775.77M -44.45M -82.28M

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (MEDP CIK 0001668397), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

ESE

ESCO TECHNOLOGIES INC.

NXDR

Nextdoor Holdings, Inc

WTW

WILLIS TOWERS WATSON PLC